Summary
Datamonitor's Endo Pharmaceuticals Holdings Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Endo Pharmaceuticals (Endo) engages in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used for the treatment and management of pain. The company primarily operates in the US. Endo is headquartered in Chadds Ford, Pennsylvania and employs about 1,000 people. The company recorded revenues of $1,085.6million during the fiscal year ended December 2007, an increase of 19.3% over 2006. The operating profit of the company was $317.2 million during fiscal year 2007, an increase of 50.7% over 2006. The net profit was $227.4 million in fiscal year 2007, an increase of 65% over 2006. *Financials are unaudited http://phx.corporate-ir.net/phoenix.zhtml?c=123046&p=irol-newsArticle&ID=1111324&highlight=
Scope of the Report
- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to Purchase
- Support sales activities by understanding your customers' businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors' business structure, strategy and prospects
- Obtain the most up to date company information available.
|
